H.R. 6171 · 119th Congress · Health

ACA Copay CAP Act of 2025

In committee402 words Introduced Nov 20, 2025 · Latest action Nov 20, 2025

How far it has goneStage 2 of 6
  1. IntroducedNov 20, 2025 Done
  2. CommitteeReferred to Energy and Commerce Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

Full text

No CRS summary yet · 402 words

H.R. 6171 · Introduced in House · Nov 20, 2025

SECTION 1. SHORT TITLE.

This Act may be cited as the ACA Copay Cost and Affordability for Patients Act of 2025 or the ACA Copay CAP Act of 2025 .

SEC. 2. ESTABLISHING AN OUT-OF-POCKET LIMIT ON SPENDING FOR PRESCRIPTION DRUGS.

(a) In general. Section 1302(c) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(c) ) is amended— (1) by inserting after paragraph (1) the following new paragraph: (2) Annual limitation on cost-sharing for drugs (A) In general The annual cost-sharing incurred under a health plan with respect to prescription drugs dispensed during a plan year beginning on or after January 1, 2027, shall not exceed the dollar amount specified in subparagraph (B) with respect to such plan year. (B) Amount specified For purposes of subparagraph (B), the dollar amount specified in this subparagraph with respect to a plan year is the following: (i) With respect to self-only coverage— (I) for plan years beginning in 2027, $2,000; and (II) for plan years beginning in 2028 or a subsequent year, the dollar amount in effect under this subparagraph for plan years beginning in 2027, increased by an amount equal to the product of that amount and the premium adjustment percentage under paragraph (4) for the calendar year. (ii) With respect to coverage other than self-only coverage, for plan years beginning in 2027 or a subsequent calendar year, twice the amount in effect under clause (i) for such plan year. If the amount of any increase under clause (i) is not a multiple of $50, such increase shall be rounded to the next lowest multiple of $50. ; and (2) in paragraph (4)— (A) by striking paragraph (1)(B)(i) and inserting paragraphs (1) and (2) ; and (B) by striking (as determined by the Secretary) and inserting (or, for purposes of paragraph (2), for 2027), as determined by the Secretary .

(b) Conforming amendments. (1) PPACA Section 1302(e)(1)(B)(i) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(e)(1)(B)(i) ) is amended by inserting and except, with respect to plan years beginning on or after January 1, 2027, in the case of an individual who has incurred cost-sharing expenses with respect to prescription drugs in an amount equal to the limitation in effect under subsection (c)(2) for such plan year, for benefits consisting of prescription drugs after section 2713 . (2) PHSA Section 2707(b) of the Public Health Service Act ( 42 U.S.C. 300gg–6(b) ) is amended by inserting or (2) after paragraph (1) .

Shown here because the text is under 500 words. Open on Congress.gov

Who lobbies on it

1 organization · 4 filings · Q4 2025–Q3 2026

See which of this bill’s sponsors and cosponsors got money from America's Health Insurance Plans Inc (ahip)’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. America's Health Insurance Plans Inc (ahip) 4 of 4 quarters
    “…H.R. 6171 - ACA Copay CAP Act of 2025 - Rep. Auchincloss, Jake - establish out of pocket limit on prescription drugs H.R. 6248 - Healthy Competition for Better Care Act - Rep. Arrington, Jodey - ban anticompetitive terms in contracts, promote higher quality, lower cost care H.R. 6703 - Lower Health Care Premiums for…”

    $11.3M lobbying spend in 2026 to date, all issuesQ3 2026 filing

Organizations that named H.R. 6171 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Nov 20, 2025Referred to the House Committee on Energy and Commerce.
  2. Nov 20, 2025Introduced in House